Harbin Pharmaceutical Group Co Ltd (600664) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.030x

Based on the latest financial reports, Harbin Pharmaceutical Group Co Ltd (600664) has a cash flow conversion efficiency ratio of -0.030x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-192.19 Million ≈ $-28.12 Million USD) by net assets (CN¥6.41 Billion ≈ $937.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View 600664 live share price for real-time trading data and today's change.

Harbin Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Harbin Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see 600664 stock market capitalisation for the company's overall valuation and market capitalisation.

Harbin Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Harbin Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Also see Harbin Pharmaceutical Group Co Ltd (600664) total assets for a full breakdown of the balance sheet.

Company	Cash Flow Conversion Efficiency
Virbac SA PA:VIRP	0.023x
Brederode SA BR:BREB	0.000x
AIR CHINA LTD H ADR/20 F:AD2B	N/A
Krungthai Card PCL BK:KTC	0.058x
Craftsman Automation Limited NSE:CRAFTSMAN	-0.039x
Wuhan Raycus Fiber Laser Technologies Co Ltd Class A SHE:300747	0.033x
BNK Financial Group Inc KO:138930	-0.113x
Sigurd Microelectronics Corp TW:6257	0.078x

Annual Cash Flow Conversion Efficiency for Harbin Pharmaceutical Group Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Harbin Pharmaceutical Group Co Ltd from 1998 to 2024. Review Harbin Pharmaceutical Group Co Ltd (600664) financial flexibility to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥6.09 Billion ≈ $891.05 Million	CN¥792.50 Million ≈ $115.97 Million	0.130x	-25.68%
2023-12-31	CN¥5.42 Billion ≈ $793.53 Million	CN¥949.67 Million ≈ $138.97 Million	0.175x	+39.38%
2022-12-31	CN¥4.95 Billion ≈ $724.49 Million	CN¥622.09 Million ≈ $91.03 Million	0.126x	+441.93%
2021-12-31	CN¥4.42 Billion ≈ $646.86 Million	CN¥-162.44 Million ≈ $-23.77 Million	-0.037x	+79.87%
2020-12-31	CN¥3.99 Billion ≈ $583.65 Million	CN¥-728.15 Million ≈ $-106.55 Million	-0.183x	-280.76%
2019-12-31	CN¥5.94 Billion ≈ $869.62 Million	CN¥-284.94 Million ≈ $-41.70 Million	-0.048x	-143.47%
2018-12-31	CN¥6.28 Billion ≈ $919.10 Million	CN¥692.72 Million ≈ $101.37 Million	0.110x	+452.97%
2017-12-31	CN¥7.48 Billion ≈ $1.09 Billion	CN¥149.22 Million ≈ $21.84 Million	0.020x	-94.04%
2016-12-31	CN¥8.30 Billion ≈ $1.21 Billion	CN¥2.78 Billion ≈ $406.51 Million	0.335x	+50.91%
2015-12-31	CN¥7.48 Billion ≈ $1.09 Billion	CN¥1.66 Billion ≈ $242.91 Million	0.222x	+71.25%
2014-12-31	CN¥8.77 Billion ≈ $1.28 Billion	CN¥1.14 Billion ≈ $166.25 Million	0.130x	+702.39%
2013-12-31	CN¥8.77 Billion ≈ $1.28 Billion	CN¥141.64 Million ≈ $20.73 Million	0.016x	-74.96%
2012-12-31	CN¥8.65 Billion ≈ $1.27 Billion	CN¥557.83 Million ≈ $81.63 Million	0.064x	+1410.01%
2011-12-31	CN¥6.41 Billion ≈ $938.47 Million	CN¥-31.56 Million ≈ $-4.62 Million	-0.005x	-102.79%
2010-12-31	CN¥6.55 Billion ≈ $957.81 Million	CN¥1.15 Billion ≈ $168.67 Million	0.176x	-43.08%
2009-12-31	CN¥5.98 Billion ≈ $875.69 Million	CN¥1.85 Billion ≈ $270.95 Million	0.309x	+209.57%
2008-12-31	CN¥5.79 Billion ≈ $847.08 Million	CN¥578.59 Million ≈ $84.67 Million	0.100x	-22.30%
2007-12-31	CN¥5.05 Billion ≈ $739.58 Million	CN¥650.16 Million ≈ $95.14 Million	0.129x	-13.48%
2006-12-31	CN¥4.96 Billion ≈ $726.45 Million	CN¥738.08 Million ≈ $108.00 Million	0.149x	-13.82%
2005-12-31	CN¥4.39 Billion ≈ $642.77 Million	CN¥757.76 Million ≈ $110.88 Million	0.173x	+352.24%
2004-12-31	CN¥3.91 Billion ≈ $571.61 Million	CN¥149.01 Million ≈ $21.80 Million	0.038x	-60.58%
2003-12-31	CN¥3.13 Billion ≈ $457.96 Million	CN¥302.83 Million ≈ $44.31 Million	0.097x	-27.37%
2002-12-31	CN¥2.88 Billion ≈ $421.18 Million	CN¥383.44 Million ≈ $56.11 Million	0.133x	-40.95%
2001-12-31	CN¥2.68 Billion ≈ $391.86 Million	CN¥604.13 Million ≈ $88.40 Million	0.226x	-32.31%
2000-12-31	CN¥1.63 Billion ≈ $237.84 Million	CN¥541.70 Million ≈ $79.27 Million	0.333x	+14.09%
1999-12-31	CN¥1.48 Billion ≈ $216.01 Million	CN¥431.22 Million ≈ $63.10 Million	0.292x	+67.75%
1998-12-31	CN¥1.27 Billion ≈ $186.06 Million	CN¥221.41 Million ≈ $32.40 Million	0.174x	--

About Harbin Pharmaceutical Group Co Ltd

SHG:600664 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.01 Billion

CN¥20.58 Billion CNY

Market Cap Rank

#4959 Global

#836 in China

Share Price

CN¥8.17

Change (1 day)

-10.02%

52-Week Range

CN¥2.93 - CN¥9.12

All Time High

CN¥9.12